Mandate

Vinge advises EQT Infrastructure and GlobalConnect in connection with their SEK 3 billion acquisition of Telenor’s Open Universe and SDU fiber assets

Vinge advises EQT Infrastructure and its portfolio company GlobalConnect on the SEK 3 billion acquisition of Telenor’s Open Universe platform and SDU fiber infrastructure.

GlobalConnect will continue to build on Open Universe’s robust platform and business model, keeping the brand name and operating model intact and is committed to maintain a strong collaboration with municipalities, property owners and city networks. With additional resources and dedicated focus, GlobalConnect’s ambition is to deliver more, and improved fiber based broadband services to households across Sweden.

The transaction makes GlobalConnect one of the leading communications operators in the country. The acquired SDU fiber infrastructure will be incorporated into GlobalConnect’s FTTH operations, enabling further expansion and densification in the areas where the infrastructure is deployed.

The transaction is subject to customary regulatory conditions and is expected to be completed in Q1 2022.

Vinge’s team consisted of Daniel Rosvall, Karl Klackenberg, Milad Kamali and Eléonore Friberg (M&A), Mathilda Persson and Lisa Hörnqvist (Commercial Agreements), Sebastian Örndahl (Antitrust and Telecom Regulatory), Kristoffer Larson (Real Estate), Ebba Svenburg (Employment) and Sara Dahlros Sköld (VDR specialist).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026